Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2016

Every FDA drug recall initiated in 2016, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,199 recalls, newest first.

Class I · High risk

Cetylev (acetylcysteine)

Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.

Terminated Packaging defect Arbor Pharmaceuticals Inc. NDC 24338-700-10 D-0105-2017
Class II · Moderate risk

Venlafaxine HCL ER Capsule USP

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Terminated Dissolution failure Zydus Pharmaceuticals USA Inc NDC 68382-035-06 D-1461-2016
Class II · Moderate risk

Venlafaxine HCL ER Capsule USP

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Terminated Dissolution failure Zydus Pharmaceuticals USA Inc NDC 68382-036-06 D-1460-2016
Class III · Low risk

Children's Qnasl 40 mcg

Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.

Terminated Wrong potency / content Teva North America NDC 59310-206-08 D-1453-2016
Class I · High risk

Diocto Liquid

Microbial contamination of Non-Sterile Products; positive findings of Burkholderia cepacia

Terminated Microbial contamination The Harvard Drug Group NDC 0536-0590-85 D-0022-2017

Recalls by year